Submission of Matters to a Vote of Security Holders Form 8 K

At the Annual Meeting of Stockholders of Precigen, Inc. (the "Company") held on July 5, 2024 (the "2024 Annual Meeting"), the Company's stockholders approved an amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan (the "2023 Plan") to increase the number of shares of common stock available for issuance under the 2023 Plan by 2,000,000 shares (the "2023 Plan Amendment"). The approval of the 2023 Plan Amendment had been previously approved by the Company's Board of Directors (the "Board"), subject to stockholder approval.

The 2023 Plan Amendment amends the 2023 Plan, which was previously approved by the Company's stockholders on June 8, 2023. The principal features of the 2023 Plan Amendment are described in detail under "Proposal 4 - Approval of an Amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan (the "2023 Plan")" of the Company's Definitive Proxy Statement on Schedule 14A for the 2024 Annual Meeting filed by the Company with the Securities and Exchange Commission on May 28, 2024 (the "Proxy Statement"). The full text of the 2023 Plan Amendment is attached as Annex A to the Proxy Statement.

As previously disclosed in the Proxy Statement, Dean Mitchell did not stand for re-election at 2024 Annual Meeting. Accordingly, Mr. Mitchell's term on the Board ended effective as of July 5, 2024. Mr. Mitchell's decision not to stand for re-election was not the result of any disagreement between the Company and him on any matter relating to the Company's operations, policies or practices.

As described under Item 5.07 below, at the 2024 Annual Meeting, Nancy Howell Agee was elected to the Board, effective as of July 5, 2024.